4-Chloro-6-iodoquinazoline | CAS:98556-31-1

We serve 4-Chloro-6-iodoquinazoline CAS:98556-31-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Chloro-6-iodoquinazoline

Chemical Name:4-Chloro-6-iodoquinazoline
CAS.NO:98556-31-1
Synonyms:4-Chloro-6-iodoquinazoline
6-iodo-4-chloroquinazoline
4-chloro-6-iodo-4-quinazoline
4-chloro-6-iodo-quinazoline
 
Physical and Chemical Properties:
Density 2.0±0.1 g/cm3
Boiling Point 363.2±22.0 °C at 760 mmHg
Molecular Formula C8H4ClIN2
Molecular Weight 290.488
Flash Point 173.4±22.3 °C
 
Specification:
Appearance:Off-white to grey powder
Assay:≥95.0%
Loss on drying:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lapatinib(CAS:231277-92-2) and Lapatinib ditosylate(CAS:388082-78-8).



Contact us for information like 4-Chloro-6-iodoquinazoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-6-iodo-quinazoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-6-iodo-4-quinazoline Use and application,4-chloro-6-iodo-quinazoline technical grade,usp/ep/jp grade.


Related News: “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.4,4,4-Trifluoro-1-(4-methylphenyl)butane-1,3-dione manufacturer “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-one supplier The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.10-ACETOXY-1-CHLORODECANE vendor Apple is temporarily closing all of its stores in China because of the coronavirus outbreak.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.